{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:40:31Z","timestamp":1738600831158,"version":"3.35.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,3]]},"DOI":"10.7759\/cureus.78428","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:02:32Z","timestamp":1738598552000},"source":"Crossref","is-referenced-by-count":0,"title":["Presentation, Treatment, and Outcome of a First Stroke-like Episode in a Carrier of the Compound Heterozygous Variants c.695G_A and c.2209G_C in POLG: A Case Report"],"prefix":"10.7759","author":[{"given":"Dominik","family":"Zieglg\u00e4nsberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Finsterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1515\/medgen-2021-2090","article-title":"A perspective on human cell models for POLG-spectrum disorders: advantages and disadvantages of CRISPR-Cas-based vs. patient-derived iPSC models","volume":"33","author":"Cakmak C","year":"2021","unstructured":"Cakmak C, Zempel H. A perspective on human cell models for POLG-spectrum disorders: advantages and disadvantages of CRISPR-Cas-based vs. patient-derived iPSC models. Med Genet. 2021, 33:245-9. 10.1515\/medgen-2021-2090","journal-title":"Med Genet"},{"key":"ref2","article-title":"Sensory ataxic neuropathy with dysarthria\/dysphagia and ophthalmoplegia (SANDO). Two case reports","volume":"30","author":"G\u00e1ti I","year":"2011","unstructured":"G\u00e1ti I, Danielsson O, Jonasson J, Landtblom AM. Sensory ataxic neuropathy with dysarthria\/dysphagia and ophthalmoplegia (SANDO). Two case reports. Acta Myol. 2011, 30:188-90.","journal-title":"Acta Myol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0101-0","article-title":"POLG-related disorders and their neurological manifestations","volume":"15","author":"Rahman S","year":"2019","unstructured":"Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol. 2019, 15:40-52. 10.1038\/s41582-018-0101-0","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10110768","article-title":"POLG1-related epilepsy: review of diagnostic and therapeutic findings","volume":"10","author":"Specchio N","year":"2020","unstructured":"Specchio N, Pietrafusa N, Calabrese C, et al.. POLG1-related epilepsy: review of diagnostic and therapeutic findings. Brain Sci. 2020, 10:768. 10.3390\/brainsci10110768","journal-title":"Brain Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-259426","article-title":"Oculomasticatory rhythmic movements, insomnia and stroke-like episodes in a patient with POLG mutation","volume":"17","author":"Ramesh R","year":"2024","unstructured":"Ramesh R, Amanmahanya C, Krishnamoorthy V, Krishnan V, Palani S, Narasimhan Ranganathan L. Oculomasticatory rhythmic movements, insomnia and stroke-like episodes in a patient with POLG mutation. BMJ Case Rep. 2024, 17:e259426. 10.1136\/bcr-2023-259426","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12211","article-title":"Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases","volume":"43","author":"Hikmat O","year":"2020","unstructured":"Hikmat O, Naess K, Engvall M, et al.. Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases. J Inherit Metab Dis. 2020, 43:726-36. 10.1002\/jimd.12211","journal-title":"J Inherit Metab Dis"},{"key":"ref7","unstructured":"NAtional Library of Medicine. POLG DNA polymerase gamma, catalytic subunit [Homo sapiens (human)]. (2025). Accessed: February 1, 2025: https:\/\/www.ncbi.nlm.nih.gov\/gene?Db=gene&Cmd=DetailsSearch&Term=5428."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2008.10.007","article-title":"DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations","volume":"1787","author":"Chan SS","year":"2009","unstructured":"Chan SS, Copeland WC. DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. Biochim Biophys Acta. 2009, 1787:312-9. 10.1016\/j.bbabio.2008.10.007","journal-title":"Biochim Biophys Acta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12313","article-title":"POLG mutations presenting as Charcot-Marie-Tooth disease","volume":"24","author":"Phillips J","year":"2019","unstructured":"Phillips J, Courel S, Rebelo AP, et al.. POLG mutations presenting as Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2019, 24:213-8. 10.1111\/jns.12313","journal-title":"J Peripher Nerv Syst"},{"key":"ref10","unstructured":"National Center for Biotechnology Information. ClinVar, NM_002693.3(POLG):c.2209G>C (p.Gly737Arg). (2024). Accessed: January 4, 2025: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000013513.87."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.20159","article-title":"Dystonia responsive to dopamine: POLG mutations should be considered if sensory neuropathy is present","volume":"14","author":"Qiu J","year":"2021","unstructured":"Qiu J, Kumar KR, Watson E, Ahmad K, Sue CM, Hayes MW. Dystonia responsive to dopamine: POLG mutations should be considered if sensory neuropathy is present. J Mov Disord. 2021, 14:157-60. 10.14802\/jmd.20159","journal-title":"J Mov Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-8","article-title":"POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome","volume":"13","author":"Cheldi A","year":"2013","unstructured":"Cheldi A, Ronchi D, Bordoni A, et al.. POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome. BMC Neurol. 2013, 13:8. 10.1186\/1471-2377-13-8","journal-title":"BMC Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2017.114","article-title":"Decreased male reproductive success in association with mitochondrial dysfunction","volume":"25","author":"Martikainen MH","year":"2017","unstructured":"Martikainen MH, Grady JP, Ng YS, et al.. Decreased male reproductive success in association with mitochondrial dysfunction. Eur J Hum Genet. 2017, 25:1162-4. 10.1038\/ejhg.2017.114","journal-title":"Eur J Hum Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.12.006","article-title":"Phenotypic and genotypic variability in Alpers syndrome","volume":"16","author":"Sofou K","year":"2012","unstructured":"Sofou K, Moslemi AR, Kollberg G, et al.. Phenotypic and genotypic variability in Alpers syndrome. Eur J Paediatr Neurol. 2012, 16:379-89. 10.1016\/j.ejpn.2011.12.006","journal-title":"Eur J Paediatr Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.jnen.0000229987.17548.6e","article-title":"POLG1 mutations associated with progressive encephalopathy in childhood","volume":"65","author":"Kollberg G","year":"2006","unstructured":"Kollberg G, Moslemi AR, Darin N, et al.. POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol. 2006, 65:758-68. 10.1097\/01.jnen.0000229987.17548.6e","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2018.07.016","article-title":"Specific EEG markers in POLG1 Alpers' syndrome","volume":"129","author":"van Westrhenen A","year":"2018","unstructured":"van Westrhenen A, Cats EA, van den Munckhof B, et al.. Specific EEG markers in POLG1 Alpers' syndrome. Clin Neurophysiol. 2018, 129:2127-31. 10.1016\/j.clinph.2018.07.016","journal-title":"Clin Neurophysiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01877.x","article-title":"Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features","volume":"50","author":"Wolf NI","year":"2009","unstructured":"Wolf NI, Rahman S, Schmitt B, et al.. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia. 2009, 50:1596-607. 10.1111\/j.1528-1167.2008.01877.x","journal-title":"Epilepsia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5721-2","article-title":"Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations","volume":"258","author":"Visser NA","year":"2011","unstructured":"Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol. 2011, 258:218-22. 10.1007\/s00415-010-5721-2","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab AW","year":"2012","unstructured":"El-Hattab AW, Hsu JW, Emrick LT, Wong LJ, Craigen WJ, Jahoor F, Scaglia F. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol Genet Metab. 2012, 105:607-14. 10.1016\/j.ymgme.2012.01.016","journal-title":"Mol Genet Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2018.12.003","article-title":"Antiepileptics and NO-precursors may be beneficial for stroke-like episodes","volume":"14","author":"Finsterer J","year":"2019","unstructured":"Finsterer J. Antiepileptics and NO-precursors may be beneficial for stroke-like episodes. eNeurologicalSci. 2019, 14:38-9. 10.1016\/j.ensci.2018.12.003","journal-title":"eNeurologicalSci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336959-presentation-treatment-and-outcome-of-a-first-stroke-like-episode-in-a-carrier-of-the-compound-heterozygous-variants-c695g_a-and-c2209g_c-in-polg-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:02:34Z","timestamp":1738598554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336959-presentation-treatment-and-outcome-of-a-first-stroke-like-episode-in-a-carrier-of-the-compound-heterozygous-variants-c695g_a-and-c2209g_c-in-polg-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.78428","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}